Ricevi le ultime notizie sulle azioni XOMA Royalty con aggiornamenti su tendenze di mercato, dati finanziari e analisi di Benzinga. Rimani informato sulle performance di XOMAP

Ultime notizie per

XOMA Royalty

XOMA Royalty Corporation - 8.625% Series A Cumulative Perpetual Preferred Stock

Panoramica

Notizie

Dividendi

Vendite allo scoperto

Rapporto azionario

XOMA Royalty Corp is a biotechnology royalty aggregator playing a role in helping biotech companies achieve their goal of improving human health. XOMA acquires the potential future economics associated with pre-commercial therapeutic candidates that have been licensed to pharmaceuticals or biotechnology companies. XOMA acquires future economic rights, the seller receives non-dilutive, non-recourse funding that can use to advance their internal drug candidate(s) or for general corporate purposes. Geographically, the company operates in Switzerland, United States, Asia Pacific, Europe and Others.

Comments

XOMA Royalty Notizie sulle azioni

Notizie

Ultime notizie per

Le persone guardano anche

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO